Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing Changes at the Ocular Surface Following the Switch From Xalatan to Travatan Z.

NCT00554411 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT00554411
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00554411 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing Changes at the Ocular Surface Following the Switch From Xalatan to Travatan Z.
Lead sponsor
University of Colorado, Denver
Phase
Observational
Overall status
Completed
Start date
November 30, 2007
Completion date
August 31, 2011
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma, monotherapy with xalatan from 1 to 18 months, ocular surface disease